Do Mineralocorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
- PMID: 34015479
- DOI: 10.1016/j.jacc.2021.04.080
Do Mineralocorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
Keywords: aldosterone antagonists; atrial fibrillation/flutter; upstream therapy.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Naccarelli has received personal fees from Janssen, Milestone, Sanofi, Omeicos, Acesion, GlaxoSmithKline, and ARCA. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.J Am Coll Cardiol. 2021 Jul 13;78(2):142-152. doi: 10.1016/j.jacc.2021.04.079. Epub 2021 May 17. J Am Coll Cardiol. 2021. PMID: 34015478 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
